Gene · 6362
Papers4,584
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,141 to 1,160 of 4,584
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Autoantibodies as Biomarker and Therapeutic Target in Systemic Sclerosis. | Biomedicines | 2022 | 36140251 | PubTator, text mining | PubMed |
| New Insights into the Alveolar Epithelium as a Driver of Acute Respiratory Distress Syndrome. | Biomolecules | 2022 | 36139112 | PubTator, text mining | PubMed |
| Comparative profiling of single-cell transcriptome reveals heterogeneity of tumor microenvironment between solid and acinar lung adenocarcinoma. | J Transl Med | 2022 | 36138435 | PubTator, text mining | PubMed |
| The Roles of Exosomes upon Metallic Ions Stimulation in Bone Regeneration. | J Funct Biomater | 2022 | 36135561 | PubTator, text mining | PubMed |
| Genetic determinants of antimicrobial resistance in three multi-drug resistant strains of Cutibacterium acnes isolated from patients with acne: a predictive in silico study. | Access Microbiol | 2022 | 36133174 | PubTator, text mining | PubMed |
| The role of tumor-associated macrophages and soluble mediators in pulmonary metastatic melanoma. | Front Immunol | 2022 | 36131942 | PubTator, text mining | PubMed |
| Antifungal immunity mediated by C-type lectin receptors may be a novel target in immunotherapy for urothelial bladder cancer. | Front Immunol | 2022 | 36131933 | PubTator, text mining | PubMed |
| Tumor-Infiltrating Myeloid Cells Confer De Novo Resistance to PD-L1 Blockade through EMT-Stromal and Tgfβ-Dependent Mechanisms. | Mol Cancer Ther | 2022 | 36129800 | PubTator, text mining | PubMed |
| Single nuclei transcriptomics of muscle reveals intra-muscular cell dynamics linked to dystrophin loss and rescue. | Commun Biol | 2022 | 36123393 | PubTator, text mining | PubMed |
| The extracellular matrix alteration, implication in modulation of drug resistance mechanism: friends or foes? | J Exp Clin Cancer Res | 2022 | 36114508 | PubTator, text mining | PubMed |
| The role of long noncoding RNAs as regulators of the epithelial-Mesenchymal transition process in oral squamous cell carcinoma cells. | Front Mol Biosci | 2022 | 36106022 | PubTator, text mining | PubMed |
| Biology of lung macrophages in health and disease. | Immunity | 2022 | 36103853 | PubTator, text mining | PubMed |
| Research progress on the mechanism by which skin macrophage dysfunction mediates chronic inflammatory injury in diabetic skin. | Front Endocrinol (Lausanne) | 2022 | 36093074 | PubTator, text mining | PubMed |
| The promising roles of macrophages in geriatric hip fracture. | Front Cell Dev Biol | 2022 | 36092716 | PubTator, text mining | PubMed |
| Exploration of the Tumor Immune Landscape and Identification of Two Novel Immunotherapy-Related Genes for Epstein-Barr virus-associated Gastric Carcinoma via Integrated Bioinformatics Analysis. | Front Surg | 2022 | 36090326 | PubTator, text mining | PubMed |
| In vivo tumor immune microenvironment phenotypes correlate with inflammation and vasculature to predict immunotherapy response. | Nat Commun | 2022 | 36085288 | PubTator, text mining | PubMed |
| Integrated analysis of the tumor microenvironment using a reconfigurable microfluidic cell culture platform. | FASEB J | 2022 | 36083096 | PubTator, text mining | PubMed |
| Association between Routine Laboratory Parameters and the Severity and Progression of Systemic Sclerosis. | J Clin Med | 2022 | 36079017 | PubTator, text mining | PubMed |
| Mechanisms Underlying Anti-Inflammatory and Anti-Cancer Properties of Stretching-A Review. | Int J Mol Sci | 2022 | 36077525 | PubTator, text mining | PubMed |
| Immunomodulatory Mechanisms of Mesenchymal Stem Cells and Their Potential Clinical Applications. | Int J Mol Sci | 2022 | 36077421 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6362/papers?page=58